305 related articles for article (PubMed ID: 14623541)
1. Estrogen and growth factor signaling pathway: basic approaches for clinical application.
Hayashi S; Sakamoto T; Inoue A; Yoshida N; Omoto Y; Yamaguchi Y
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):433-42. PubMed ID: 14623541
[TBL] [Abstract][Full Text] [Related]
2. ERE-independent ERalpha target genes differentially expressed in human breast tumors.
Glidewell-Kenney C; Weiss J; Lee EJ; Pillai S; Ishikawa T; Ariazi EA; Jameson JL
Mol Cell Endocrinol; 2005 Dec; 245(1-2):53-9. PubMed ID: 16298037
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells.
Sakamoto T; Eguchi H; Omoto Y; Ayabe T; Mori H; Hayashi S
Mol Cell Endocrinol; 2002 Jun; 192(1-2):93-104. PubMed ID: 12088871
[TBL] [Abstract][Full Text] [Related]
4. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
5. Estrogen signaling and prediction of endocrine therapy.
Hayashi S; Yamaguchi Y
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():27-31. PubMed ID: 16273356
[TBL] [Abstract][Full Text] [Related]
6. Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy.
Hayashi S; Yamaguchi Y
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):201-6. PubMed ID: 18424035
[TBL] [Abstract][Full Text] [Related]
7. Estrogen response element-GFP (ERE-GFP) introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms.
Fujiki N; Konno H; Kaneko Y; Gohno T; Hanamura T; Imami K; Ishihama Y; Nakanishi K; Niwa T; Seino Y; Yamaguchi Y; Hayashi S
J Steroid Biochem Mol Biol; 2014 Jan; 139():61-72. PubMed ID: 24128438
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
9. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Matsumoto M; Yamaguchi Y; Seino Y; Hatakeyama A; Takei H; Niikura H; Ito K; Suzuki T; Sasano H; Yaegashi N; Hayashi S
Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998
[TBL] [Abstract][Full Text] [Related]
10. Basic research for hormone-sensitivity of breast cancer.
Hayashi S; Yamaguchi Y
Breast Cancer; 2006; 13(2):123-8. PubMed ID: 16755105
[TBL] [Abstract][Full Text] [Related]
11. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
[TBL] [Abstract][Full Text] [Related]
13. A study of estrogen signaling using DNA microarray in human breast cancer.
Omoto Y; Hayashi S
Breast Cancer; 2002; 9(4):308-11. PubMed ID: 12459711
[TBL] [Abstract][Full Text] [Related]
14. Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells.
Song RX; Santen RJ; Kumar R; Adam L; Jeng MH; Masamura S; Yue W
Mol Cell Endocrinol; 2002 Jul; 193(1-2):29-42. PubMed ID: 12160999
[TBL] [Abstract][Full Text] [Related]
15. Development of cDNA microarray for expression profiling of estrogen-responsive genes.
Inoue A; Yoshida N; Omoto Y; Oguchi S; Yamori T; Kiyama R; Hayashi S
J Mol Endocrinol; 2002 Oct; 29(2):175-92. PubMed ID: 12370120
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells.
Inoue A; Omoto Y; Yamaguchi Y; Kiyama R; Hayashi SI
J Mol Endocrinol; 2004 Jun; 32(3):649-61. PubMed ID: 15171706
[TBL] [Abstract][Full Text] [Related]
17. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
[TBL] [Abstract][Full Text] [Related]
18. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595
[TBL] [Abstract][Full Text] [Related]
19. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
20. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]